KR101449587B1 - 장기 지속형 약물 제형 - Google Patents
장기 지속형 약물 제형 Download PDFInfo
- Publication number
- KR101449587B1 KR101449587B1 KR1020147004763A KR20147004763A KR101449587B1 KR 101449587 B1 KR101449587 B1 KR 101449587B1 KR 1020147004763 A KR1020147004763 A KR 1020147004763A KR 20147004763 A KR20147004763 A KR 20147004763A KR 101449587 B1 KR101449587 B1 KR 101449587B1
- Authority
- KR
- South Korea
- Prior art keywords
- micro
- another example
- nucleic acid
- organ
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84435106P | 2006-09-14 | 2006-09-14 | |
| US60/844,351 | 2006-09-14 | ||
| PCT/US2007/019774 WO2008033375A2 (en) | 2006-09-14 | 2007-09-12 | Long lasting drug formulations |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020097007654A Division KR101470472B1 (ko) | 2006-09-14 | 2007-09-12 | 장기 지속형 약물 제형 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20140029559A KR20140029559A (ko) | 2014-03-10 |
| KR101449587B1 true KR101449587B1 (ko) | 2014-10-10 |
Family
ID=39184308
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147004763A Expired - Fee Related KR101449587B1 (ko) | 2006-09-14 | 2007-09-12 | 장기 지속형 약물 제형 |
| KR1020097007654A Expired - Fee Related KR101470472B1 (ko) | 2006-09-14 | 2007-09-12 | 장기 지속형 약물 제형 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020097007654A Expired - Fee Related KR101470472B1 (ko) | 2006-09-14 | 2007-09-12 | 장기 지속형 약물 제형 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9155749B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2061515A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2010504909A (cg-RX-API-DMAC7.html) |
| KR (2) | KR101449587B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN102886052B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007294858B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2664318C (cg-RX-API-DMAC7.html) |
| IL (3) | IL197557A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008033375A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7468242B2 (en) | 2001-11-05 | 2008-12-23 | Medgenics, Inc. | Dermal micro organs, methods and apparatuses for producing and using the same |
| US8501396B2 (en) | 2001-11-05 | 2013-08-06 | Medgenics Medical Israel Ltd. | Dermal micro-organs, methods and apparatuses for producing and using the same |
| CA2788000C (en) | 2003-05-01 | 2016-03-15 | Medgenics Inc. | Apparatus for harvesting a dermal micro-organ |
| US20130171107A1 (en) * | 2006-09-14 | 2013-07-04 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
| JP2010504909A (ja) * | 2006-09-14 | 2010-02-18 | メドジェニクス・メディカル・イスラエル・リミテッド | 長期持続性の医薬製剤 |
| US8454948B2 (en) | 2006-09-14 | 2013-06-04 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
| US20120129770A1 (en) * | 2009-06-22 | 2012-05-24 | Rajyashri Karur Ramakrishna | Novel polynucleotide molecules for enhanced gene expression |
| AU2011268458B2 (en) * | 2010-06-15 | 2014-06-12 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
| WO2013069016A2 (en) * | 2011-11-09 | 2013-05-16 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
| US20150183850A1 (en) * | 2012-05-18 | 2015-07-02 | University Of Iowa Research Foundation | Methods and compositions for treating amyloid deposits |
| US20160122713A1 (en) * | 2014-10-14 | 2016-05-05 | Medgenics Medical Israel Ltd. | Genetically-modified micro-organ secreting a therapeutic peptide and methods of use thereof |
| KR20180014051A (ko) * | 2015-05-28 | 2018-02-07 | 코넬 유니버시티 | 혈관 부종 치료제로서의 아데노-관련 바이러스 매개 c1e1의 전달 |
| WO2017122093A1 (en) * | 2016-01-11 | 2017-07-20 | Medgenics Medical Israel Ltd. | Compositions and methods for treatment of central nervous system diseases |
| RS61944B1 (sr) | 2016-02-19 | 2021-07-30 | Eiger Biopharmaceuticals Inc | Lečenje infekcije hepatitis delta virusom sa interferonom lambda |
| US20190142901A1 (en) * | 2017-11-16 | 2019-05-16 | Claresa Levetan | Compositions and methods for treating or preventing type 1 diabetes using a biologic response modifier in combination with one or more islet or beta cell regeneration or replacement therapies |
| CN111118016B (zh) * | 2018-10-30 | 2022-04-15 | 上海朗昇生物科技有限公司 | 治疗视网膜色素变性疾病的基因治疗载体 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002506647A (ja) * | 1998-03-19 | 2002-03-05 | バレンティス・インコーポレーテッド | インターフェロンαプラスミドおよび送達システム、およびこれを作製しそして使用する方法 |
| WO2004099363A2 (en) * | 2003-05-01 | 2004-11-18 | Medgenics Inc. | Dermal micro organs, methods and apparatuses for producing and using the same |
| US20050188431A1 (en) * | 1997-10-16 | 2005-08-25 | AviGenics,Inc | Transgenic avians and protein production |
Family Cites Families (170)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US376511A (en) | 1888-01-17 | James d | ||
| US1516071A (en) * | 1921-11-02 | 1924-11-18 | Stanley L Apolant | Method of performing skin-grafting operations and surgical instrument used therefor |
| US3076461A (en) * | 1956-12-31 | 1963-02-05 | Meek Cicero Parker | Microdermatome |
| US3470782A (en) * | 1966-01-03 | 1969-10-07 | Eric O Acker | Slitting machine |
| US3613242A (en) * | 1966-12-29 | 1971-10-19 | Michigan Research Corp | Skin graft cutter |
| CA992255A (en) * | 1971-01-25 | 1976-07-06 | Cutter Laboratories | Prosthesis for spinal repair |
| DE7235643U (de) * | 1972-09-28 | 1974-06-27 | Fischer A | Hüftgelenkkopfprothese |
| US4115346A (en) * | 1974-02-12 | 1978-09-19 | Kulzer & Co. Gmbh | Hydroxy group containing diesters of acrylic acids and their use in dental material |
| US4043343A (en) * | 1975-08-01 | 1977-08-23 | Williams Robert W | Forceps |
| US4391909A (en) * | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
| DE2939057C3 (de) | 1979-09-27 | 1982-02-25 | Aesculap-Werke Ag Vormals Jetter & Scheerer, 7200 Tuttlingen | Schneidvorrichtung zum Einbringen von Schnitten in die Haut |
| SE420009B (sv) * | 1979-12-21 | 1981-09-07 | Ericsson Telefon Ab L M | Expanderskruv for fastsettning i en halighet |
| US4369788A (en) * | 1980-01-31 | 1983-01-25 | Goald Harold J | Reversed forceps for microdisc surgery |
| US4353888A (en) * | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
| DE3247387C2 (de) * | 1982-12-22 | 1984-11-22 | Rolf Prof. Dr.med. 7400 Tübingen Hettich | Verfahren zur Herstellung eines Transplantats und Vorrichtung zur Durchführung des Verfahrens |
| NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
| KR850004274A (ko) * | 1983-12-13 | 1985-07-11 | 원본미기재 | 에리트로포이에틴의 제조방법 |
| US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
| US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
| DE3432897C2 (de) | 1984-09-07 | 1986-07-03 | Aesculap-Werke Ag Vormals Jetter & Scheerer, 7200 Tuttlingen | Hautnetz-Dermatom |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| JPS61233694A (ja) | 1985-04-08 | 1986-10-17 | Morinaga & Co Ltd | ウシ脾臓中に含まれる成長因子及びその単離方法 |
| US4667016A (en) * | 1985-06-20 | 1987-05-19 | Kirin-Amgen, Inc. | Erythropoietin purification |
| US4966849A (en) * | 1985-09-20 | 1990-10-30 | President And Fellows Of Harvard College | CDNA and genes for human angiogenin (angiogenesis factor) and methods of expression |
| US5266480A (en) * | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
| EP0260032B1 (en) | 1986-09-08 | 1994-01-26 | Ajinomoto Co., Inc. | Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and starting materials for the synthesis of said oligomers |
| US4954437A (en) | 1986-09-15 | 1990-09-04 | Integrated Genetics, Inc. | Cell encoding recombinant human erythropoietin |
| US5759830A (en) | 1986-11-20 | 1998-06-02 | Massachusetts Institute Of Technology | Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo |
| US4883666A (en) * | 1987-04-29 | 1989-11-28 | Massachusetts Institute Of Technology | Controlled drug delivery system for treatment of neural disorders |
| EP0289121B1 (en) | 1987-05-01 | 1995-12-27 | Stratagene | Mutagenesis testing using transgenic non-human animals carrying test DNA sequences |
| US4951684A (en) * | 1987-05-15 | 1990-08-28 | Syntex (U.S.A.) Inc. | Device for collecting biological material |
| JPS63185396U (cg-RX-API-DMAC7.html) | 1987-05-21 | 1988-11-29 | ||
| US5175385A (en) | 1987-09-03 | 1992-12-29 | Ohio University/Edison Animal Biotechnolgy Center | Virus-resistant transgenic mice |
| US4892538A (en) * | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| US5106627A (en) * | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
| JP3019994B2 (ja) | 1987-11-30 | 2000-03-15 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | 新規なオリゴデオキシヌクレオチド、それを使用した標的遺伝子の発現をブロックする方法、及び新規なオリゴデオキシヌクレオチド並びにそれを使用した標的遺伝子の発現を阻止する方法 |
| US5024841A (en) | 1988-06-30 | 1991-06-18 | Collagen Corporation | Collagen wound healing matrices and process for their production |
| US5221778A (en) | 1988-08-24 | 1993-06-22 | Yale University | Multiplex gene regulation |
| CA2000181A1 (en) | 1988-10-14 | 1990-04-14 | Chung-Faye Chao | Process for producing cultured epidermal sheet, product and method of use |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US5175383A (en) | 1989-02-17 | 1992-12-29 | President And Fellows Of Harvard College | Animal model for benign prostatic disease |
| US5256775A (en) | 1989-06-05 | 1993-10-26 | Gilead Sciences, Inc. | Exonuclease-resistant oligonucleotides |
| US5043711A (en) | 1989-06-09 | 1991-08-27 | Xerox Corporation | Representation of polygons defined by non-zero winding numbers |
| US4973301A (en) * | 1989-07-11 | 1990-11-27 | Israel Nissenkorn | Catheter and method of using same |
| US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| US5012841A (en) * | 1989-08-24 | 1991-05-07 | Keystone International Holdings Corp. | Pressure reducing and conditioning valves |
| JPH0390237A (ja) | 1989-08-31 | 1991-04-16 | Matsutani Seisakusho Co Ltd | アイレス縫合針の加工方法 |
| DE3936703A1 (de) * | 1989-11-03 | 1991-05-08 | Lutz Biedermann | Knochenschraube |
| US5059193A (en) * | 1989-11-20 | 1991-10-22 | Spine-Tech, Inc. | Expandable spinal implant and surgical method |
| CH680564A5 (cg-RX-API-DMAC7.html) * | 1989-12-07 | 1992-09-30 | Experimentelle Chirurgie Schwe | |
| US5623065A (en) | 1990-08-13 | 1997-04-22 | Isis Pharmaceuticals, Inc. | Gapped 2' modified oligonucleotides |
| DE4104092A1 (de) | 1990-02-13 | 1991-08-14 | Christoph Dr Med Rieger | Von einem flexiblen kunststoffschlauch ueberzogene metallkanuele |
| US5220007A (en) | 1990-02-15 | 1993-06-15 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of RNA and production of encoded polypeptides |
| US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| CA2080693C (en) * | 1990-04-24 | 2001-11-27 | Mark Eisenberg | Composite living skin equivalents |
| JPH06507782A (ja) | 1990-06-15 | 1994-09-08 | サイオス ノバ インコーポレイテッド | アルツハイマー病のアミロイド形成開症状を示すヒト以外の組換え哺乳動物 |
| US5236445A (en) * | 1990-07-02 | 1993-08-17 | American Cyanamid Company | Expandable bone anchor and method of anchoring a suture to a bone |
| US5725529A (en) * | 1990-09-25 | 1998-03-10 | Innovasive Devices, Inc. | Bone fastener |
| CA2092400A1 (en) * | 1990-09-25 | 1992-03-26 | James E. Nicholson | Bone fastener |
| US5288846A (en) | 1990-10-19 | 1994-02-22 | The General Hospital Corporation | Cell specific gene regulators |
| US5720753A (en) * | 1991-03-22 | 1998-02-24 | United States Surgical Corporation | Orthopedic fastener |
| SG47470A1 (en) | 1991-04-25 | 1998-04-17 | Univ Brown Res Found | Implantable biocompatible immunoisolatory vehicle for delivery of a selected therapeutic products |
| JP2576302B2 (ja) * | 1991-04-26 | 1997-01-29 | ヤマハ株式会社 | 楽音合成装置 |
| GB9112898D0 (en) * | 1991-06-14 | 1991-07-31 | Digital Equipment Int | Communication networks |
| DE69231250T2 (de) * | 1991-10-21 | 2001-03-15 | Cell Genesys, Inc. | Kombinierte zelluläre und immunsuppressive therapien |
| US5298422A (en) | 1991-11-06 | 1994-03-29 | Baylor College Of Medicine | Myogenic vector systems |
| US5700922A (en) | 1991-12-24 | 1997-12-23 | Isis Pharmaceuticals, Inc. | PNA-DNA-PNA chimeric macromolecules |
| DE69233109T2 (de) | 1992-01-07 | 2004-05-19 | Elan Pharmaceuticals, Inc., San Francisco | Transgene tiermodelle fur alzheimer-krankheit |
| US5360735A (en) | 1992-01-08 | 1994-11-01 | Synaptic Pharmaceutical Corporation | DNA encoding a human 5-HT1F receptor, vectors, and host cells |
| US5958764A (en) * | 1992-04-30 | 1999-09-28 | Baylor College Of Medicine | Specific expression vectors and methods of use |
| WO1993022430A1 (en) | 1992-04-30 | 1993-11-11 | Baylor College Of Medicine | Development of a vector to target gene expression to the epidermis of transgenic animals |
| JP2660641B2 (ja) * | 1992-07-22 | 1997-10-08 | 株式会社東洋設計 | ロール混練機の材料巻込み機構 |
| US5652355A (en) | 1992-07-23 | 1997-07-29 | Worcester Foundation For Experimental Biology | Hybrid oligonucleotide phosphorothioates |
| EP0663952A4 (en) | 1992-09-11 | 1997-06-11 | Univ California | TRANSGENIC ANIMALS HAVING TARGET LYMPHOCYTA TRANSDUCTION GENES. |
| US5888720A (en) * | 1992-10-27 | 1999-03-30 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | In vitro micro-organs |
| US5423330A (en) * | 1993-03-10 | 1995-06-13 | The University Of Miami | Capsule suction punch instrument and method of use |
| SG49754A1 (en) | 1993-03-16 | 1998-06-15 | Photogenesis Inc | Method for preparation and transplantation of volute grafts and surgical instrument therefor |
| WO1994023049A2 (en) | 1993-04-02 | 1994-10-13 | The Johns Hopkins University | The introduction and expression of large genomic sequences in transgenic animals |
| US6664107B1 (en) | 1993-05-26 | 2003-12-16 | Ontario Cancer Institute, University Health Network | CD45 disrupted nucleic acid |
| US5423850A (en) * | 1993-10-01 | 1995-06-13 | Berger; J. Lee | Balloon compressor for internal fixation of bone fractures |
| US5480400A (en) * | 1993-10-01 | 1996-01-02 | Berger; J. Lee | Method and device for internal fixation of bone fractures |
| DK0733059T3 (da) | 1993-12-09 | 2000-10-16 | Univ Jefferson | Forbindelser og fremgangsmåder til site-rettede mutationer i eukaryote celler |
| US6248110B1 (en) * | 1994-01-26 | 2001-06-19 | Kyphon, Inc. | Systems and methods for treating fractured or diseased bone using expandable bodies |
| JP3333211B2 (ja) * | 1994-01-26 | 2002-10-15 | レイリー,マーク・エイ | 骨の治療に関する外科的方法で使用される、改良に係る拡張可能な装置 |
| US5477862A (en) * | 1994-03-14 | 1995-12-26 | Haaga; John R. | Cutting tip for biopsy needle |
| EP0679402B1 (en) * | 1994-04-25 | 2003-09-10 | Japan Science and Technology Corporation | Biologically active substance-secreting hybrid gel |
| US6001647A (en) * | 1994-04-28 | 1999-12-14 | Ixion Biotechnology, Inc. | In vitro growth of functional islets of Langerhans and in vivo uses thereof |
| US5622866A (en) * | 1994-06-23 | 1997-04-22 | Merck & Co., Inc. | Expression cassettes useful in construction of integrative and replicative expression vectors for Streptomyces |
| US5693064A (en) | 1994-11-04 | 1997-12-02 | Arnold; James E. | Dermal punch for hair transplantation and methods |
| US20030157074A1 (en) * | 1994-11-16 | 2003-08-21 | Mitrani Eduardo N. | Vitro micro-organs, and uses related thereto |
| US6472200B1 (en) * | 1999-07-23 | 2002-10-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Device and method for performing a biological modification of a fluid |
| WO2003035851A1 (en) | 2001-10-23 | 2003-05-01 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | In vitro micro-organs, and uses related thereto |
| JP3091113B2 (ja) | 1994-11-22 | 2000-09-25 | 科学技術振興事業団 | 生理活性物質分泌性のハイブリッド型ゲル |
| US5782851A (en) * | 1996-04-10 | 1998-07-21 | Rassman; William R. | Hair transplantation system |
| US5652256A (en) | 1995-06-06 | 1997-07-29 | Knowles; W. Roy | Topical composition for fungal treatment |
| US5861313A (en) * | 1995-06-07 | 1999-01-19 | Ontogeny, Inc. | Method of isolating bile duct progenitor cells |
| US5985653A (en) * | 1995-06-07 | 1999-11-16 | Aastrom Biosciences, Inc. | Incubator apparatus for use in a system for maintaining and growing biological cells |
| US5591444A (en) | 1995-07-28 | 1997-01-07 | Isolagen Technologies, Inc. | Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| JPH11511975A (ja) | 1995-08-25 | 1999-10-19 | ライフセル コーポレイション | 再構成皮膚 |
| US5857982A (en) * | 1995-09-08 | 1999-01-12 | United States Surgical Corporation | Apparatus and method for removing tissue |
| US6090618A (en) | 1996-10-07 | 2000-07-18 | Arch Development Corporation | DNA constructs and viral vectors comprising a smooth muscle promoter |
| US5782830A (en) * | 1995-10-16 | 1998-07-21 | Sdgi Holdings, Inc. | Implant insertion device |
| US5932459A (en) * | 1995-10-20 | 1999-08-03 | Sittinger; Michael | Artificial tissues, methods for the production and the use thereof |
| US6071284A (en) * | 1995-10-30 | 2000-06-06 | Biomedical Enterprises, Inc. | Materials collection system and uses thereof |
| DE19607517C1 (de) * | 1996-02-28 | 1997-04-10 | Lutz Biedermann | Knochenschraube |
| WO1998010086A1 (en) * | 1996-09-06 | 1998-03-12 | Trustees Of The University Of Pennsylvania | Methods using cre-lox for production of recombinant adeno-associated viruses |
| NL1004276C2 (nl) | 1996-10-15 | 1998-04-20 | Willem Marie Ysebaert | Werkwijzen voor het vervaardigen van huideilandjes, voor het verplaatsen van huid of huideilandjes, voor het spreiden van huideilandjes en het aanbrengen hiervan op een brandwond, alsmede een houder, snijraam, snijtafel, contradrager, klemorgaan, membraan, transportorgaan en spreidingsorgaan om te worden toegepast voor dergelijke werkwijzen. |
| IL129387A0 (en) | 1996-10-18 | 2000-02-17 | Canji Inc | Methods and compositions for delivery and expression of interferon-alpha nucleic acids |
| EP1181355A4 (en) | 1997-01-16 | 2005-05-04 | Yissum Res Dev Co | METHOD AND DEVICE FOR REALIZING A BIOLOGICAL MODIFICATION OF A FLUID |
| US5817120A (en) | 1997-02-10 | 1998-10-06 | Rassman; William R. | Hair implanting instrument |
| DE69830320T2 (de) | 1997-03-07 | 2006-02-02 | The Wistar Institute Of Anatomy And Biology | Verwendung von Adenoviralen Vektoren, die PDGF oder VEGF exprimieren, ZUR HEILUNG VON GEWEBSDEFEKTEN UND ZUR INDUZIERUNG DER HYPERVASKULITÄT IN SÄUGERGEWEBEN |
| US6110459A (en) | 1997-05-28 | 2000-08-29 | Mickle; Donald A. G. | Transplants for myocardial scars and methods and cellular preparations |
| US5972015A (en) * | 1997-08-15 | 1999-10-26 | Kyphon Inc. | Expandable, asymetric structures for deployment in interior body regions |
| US6171812B1 (en) | 1997-07-15 | 2001-01-09 | The National Institute Of Biogerontology, Inc. | Combined perfusion and mechanical loading system for explanted bone |
| WO1999006073A1 (en) | 1997-07-31 | 1999-02-11 | St. Elizabeth's Medical Center Of Boston, Inc. | Method for the treatment of grafts |
| GB9716198D0 (en) | 1997-07-31 | 1997-10-08 | Plessey Telecomm | RAP routeing for ISO 10589 |
| JP2001514867A (ja) | 1997-08-15 | 2001-09-18 | ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ | 内皮のタンパク分解活性および/または血管形成活性の刺激、調節および/または阻害 |
| EP1014859A4 (en) | 1997-08-19 | 2007-05-02 | Philipp Lang | MEASUREMENT OF INTERSTITIAL CAPILLARY FLUID BY MEANS OF ULTRASONIC METHOD AND DEVICES |
| JP3059127B2 (ja) | 1997-09-02 | 2000-07-04 | 藤村 昭夫 | 組織工学を応用した人工臓器 |
| AU1114699A (en) | 1997-10-24 | 1999-05-17 | Children's Medical Center Corporation | Methods for promoting cell transfection (in vivo) |
| US7687057B2 (en) * | 1998-01-09 | 2010-03-30 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | In vitro micro-organs, and uses related thereto |
| US6533807B2 (en) | 1998-02-05 | 2003-03-18 | Medtronic, Inc. | Radially-expandable stent and delivery system |
| WO1999043270A1 (en) | 1998-02-24 | 1999-09-02 | Gerigene Medical Corporation | Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects |
| US6331166B1 (en) * | 1998-03-03 | 2001-12-18 | Senorx, Inc. | Breast biopsy system and method |
| EP1064353B1 (en) * | 1998-03-18 | 2002-11-06 | Massachusetts Institute Of Technology | Vascularized perfused microtissue/micro-organ arrays |
| US6303136B1 (en) * | 1998-04-13 | 2001-10-16 | Neurotech S.A. | Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane |
| US5944673A (en) * | 1998-05-14 | 1999-08-31 | Ethicon Endo-Surgery, Inc. | Biopsy instrument with multi-port needle |
| US6027512A (en) | 1998-05-28 | 2000-02-22 | Bridges; Ronzee M. | Hair follicle harvesting device |
| EP1110113A4 (en) | 1998-06-29 | 2005-03-09 | Univ Syracuse | Method of fabricating a cylindrical optical fiber containing an optically active film |
| US5958767A (en) | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
| WO2000011151A2 (en) | 1998-08-25 | 2000-03-02 | University Of Georgia Research Foundation, Inc. | Direct oviduct transgenesis |
| US6326201B1 (en) | 1999-02-10 | 2001-12-04 | Curis, Inc. | Pancreatic progenitor cells, methods and uses related thereto |
| US6264659B1 (en) * | 1999-02-22 | 2001-07-24 | Anthony C. Ross | Method of treating an intervertebral disk |
| US6245101B1 (en) * | 1999-05-03 | 2001-06-12 | William J. Drasler | Intravascular hinge stent |
| KR20020018197A (ko) | 1999-05-19 | 2002-03-07 | 추후보정 | Fc 융합 단백질로서의 인터페론-알파 단백질의 발현 및분비 |
| US20030152562A1 (en) * | 2001-10-23 | 2003-08-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Vitro micro-organs, and uses related thereto |
| CA2377541A1 (en) | 1999-06-25 | 2001-01-04 | Eduardo N. Mitrani | Method of inducing angiogenesis by micro-organs |
| US20030129736A1 (en) | 1999-07-15 | 2003-07-10 | Eduardo Mitrani | Device and method for performing a biological modification of a fluid |
| WO2001008714A1 (en) | 1999-07-28 | 2001-02-08 | Regeneration Technologies, Inc. | Cartilage or bone matrix as a nucleic acid delivery vehicle |
| JP2005098702A (ja) | 1999-10-07 | 2005-04-14 | Seitai Kagaku Kenkyusho:Kk | 生物組織試料作製方法および器具 |
| AU784884B2 (en) * | 1999-12-10 | 2006-07-20 | Anticancer, Inc. | Methods for introducing genes into mammalian subjects |
| EP1238286A1 (en) | 1999-12-13 | 2002-09-11 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | High-throughput tissue microarray technology and applications |
| US6893462B2 (en) | 2000-01-11 | 2005-05-17 | Regeneration Technologies, Inc. | Soft and calcified tissue implants |
| EP1286707A2 (en) | 2000-02-18 | 2003-03-05 | Regeneration Technologies, Inc. | Implantable tissues infused with growth factors and other additives |
| WO2001071018A2 (en) * | 2000-03-22 | 2001-09-27 | Board Of Trustees Of The University Of Arkansas | Secreting products from skin by adeno-associated virus (aav) gene transfer |
| US20020154114A1 (en) * | 2000-11-30 | 2002-10-24 | Christensen Thomas Kragh | Method and system for customising build-to-order products |
| ES2184623B1 (es) | 2001-06-29 | 2004-09-16 | Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas (C.I.E.M.A.T.) | Piel artificial autologa secretora de leptina y metodo de obtencion. |
| EP1411769A4 (en) * | 2001-07-09 | 2004-12-29 | Medgenics Inc | EFFECTIVE METHODS FOR THE EVALUATION AND VALIDATION OF PROTEIN-BASED CANDIDATE THERAPEUTIC MOLECULES, ENCODED BY TARGETED NUCLEOTIDE SEQUENCES |
| US20050053587A1 (en) * | 2001-09-20 | 2005-03-10 | Jacques Galipeau | Cultured stromal cells and uses thereof |
| KR100970195B1 (ko) | 2001-10-23 | 2010-07-14 | 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 | 시험관내 미세기관 및 이에 관련된 용도 |
| US7468242B2 (en) * | 2001-11-05 | 2008-12-23 | Medgenics, Inc. | Dermal micro organs, methods and apparatuses for producing and using the same |
| US20070183974A1 (en) | 2001-11-05 | 2007-08-09 | Pearlman Andrew L | Method and apparatus for production of a skin graft and the graft produced thereby |
| HU229475B1 (en) | 2001-12-06 | 2014-01-28 | Fibrogen | Methods of increasing endogenous erythropoietin (epo) |
| JP3806900B2 (ja) | 2001-12-11 | 2006-08-09 | 独立行政法人産業技術総合研究所 | 育毛剤 |
| US7297540B2 (en) | 2002-01-15 | 2007-11-20 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs |
| JP2005533102A (ja) | 2002-07-12 | 2005-11-04 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム | 微小器官によって生物学的プロセスを誘発する方法と装置 |
| US7666134B2 (en) * | 2002-09-28 | 2010-02-23 | Kci Licensing, Inc. | System and method for transplantation of dermal tissue |
| US20040091961A1 (en) * | 2002-11-08 | 2004-05-13 | Evans Glen A. | Enhanced variants of erythropoietin and methods of use |
| NZ540043A (en) * | 2002-11-18 | 2007-11-30 | Maxygen Inc | Isolated or recombinant Interferon-alpha polypeptides and conjugates |
| US7708746B2 (en) * | 2003-02-27 | 2010-05-04 | Wright Medical Technology, Inc. | Method and apparatus for processing dermal tissue |
| CN100515354C (zh) | 2003-02-27 | 2009-07-22 | 应用纸巾技术有限公司 | 用于处理皮肤组织的方法和设备 |
| WO2004078916A2 (en) | 2003-03-03 | 2004-09-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | In vitro micro-organs, and uses related thereto |
| US20050090777A1 (en) * | 2003-10-23 | 2005-04-28 | Carter Travis S. | Surgical irrigation system |
| DE102004037611B4 (de) * | 2004-08-03 | 2013-10-02 | Geneart Ag | Induzierbare Genexpression |
| WO2006110843A2 (en) | 2005-04-12 | 2006-10-19 | Applied Tissue Technologies Llc | Engineered deremal tissue particles and transplantation methods |
| US7785339B2 (en) | 2005-08-09 | 2010-08-31 | Innovia, Llc | Tool for coring portions of one or more hair follicles |
| JP4600373B2 (ja) * | 2006-09-12 | 2010-12-15 | 株式会社デンソー | 車両用交流発電機 |
| US8454948B2 (en) * | 2006-09-14 | 2013-06-04 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
| JP2010504909A (ja) * | 2006-09-14 | 2010-02-18 | メドジェニクス・メディカル・イスラエル・リミテッド | 長期持続性の医薬製剤 |
| AU2011268458B2 (en) * | 2010-06-15 | 2014-06-12 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
-
2007
- 2007-09-12 JP JP2009528264A patent/JP2010504909A/ja active Pending
- 2007-09-12 AU AU2007294858A patent/AU2007294858B2/en not_active Ceased
- 2007-09-12 KR KR1020147004763A patent/KR101449587B1/ko not_active Expired - Fee Related
- 2007-09-12 CN CN201210365694.XA patent/CN102886052B/zh not_active Expired - Fee Related
- 2007-09-12 CA CA2664318A patent/CA2664318C/en not_active Expired - Fee Related
- 2007-09-12 EP EP07838055A patent/EP2061515A4/en not_active Withdrawn
- 2007-09-12 US US11/898,481 patent/US9155749B2/en not_active Expired - Fee Related
- 2007-09-12 KR KR1020097007654A patent/KR101470472B1/ko not_active Expired - Fee Related
- 2007-09-12 CN CN200780042395XA patent/CN101610793B/zh not_active Expired - Fee Related
- 2007-09-12 WO PCT/US2007/019774 patent/WO2008033375A2/en not_active Ceased
-
2009
- 2009-03-12 IL IL197557A patent/IL197557A/en not_active IP Right Cessation
-
2011
- 2011-06-30 US US13/172,915 patent/US8586024B2/en not_active Expired - Fee Related
-
2012
- 2012-01-30 IL IL217840A patent/IL217840A/en not_active IP Right Cessation
- 2012-01-30 IL IL217841A patent/IL217841A/en not_active IP Right Cessation
-
2014
- 2014-08-21 JP JP2014168085A patent/JP6039617B2/ja not_active Expired - Fee Related
-
2015
- 2015-07-17 US US14/802,461 patent/US20160051627A1/en not_active Abandoned
-
2016
- 2016-11-04 JP JP2016216033A patent/JP2017048231A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050188431A1 (en) * | 1997-10-16 | 2005-08-25 | AviGenics,Inc | Transgenic avians and protein production |
| JP2002506647A (ja) * | 1998-03-19 | 2002-03-05 | バレンティス・インコーポレーテッド | インターフェロンαプラスミドおよび送達システム、およびこれを作製しそして使用する方法 |
| WO2004099363A2 (en) * | 2003-05-01 | 2004-11-18 | Medgenics Inc. | Dermal micro organs, methods and apparatuses for producing and using the same |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2061515A2 (en) | 2009-05-27 |
| CN101610793A (zh) | 2009-12-23 |
| IL197557A (en) | 2012-10-31 |
| AU2007294858A1 (en) | 2008-03-20 |
| IL217840A0 (en) | 2012-03-29 |
| JP2010504909A (ja) | 2010-02-18 |
| US8586024B2 (en) | 2013-11-19 |
| CA2664318C (en) | 2017-05-23 |
| AU2007294858B2 (en) | 2011-05-12 |
| US20120003196A1 (en) | 2012-01-05 |
| EP2061515A4 (en) | 2013-01-30 |
| CN102886052A (zh) | 2013-01-23 |
| WO2008033375A2 (en) | 2008-03-20 |
| JP6039617B2 (ja) | 2016-12-07 |
| IL217841A (en) | 2013-04-30 |
| IL197557A0 (en) | 2009-12-24 |
| WO2008033375A3 (en) | 2008-08-14 |
| KR101470472B1 (ko) | 2014-12-09 |
| JP2017048231A (ja) | 2017-03-09 |
| KR20090083340A (ko) | 2009-08-03 |
| CN102886052B (zh) | 2014-07-30 |
| HK1180949A1 (en) | 2013-11-01 |
| IL217841A0 (en) | 2012-03-29 |
| US20080090777A1 (en) | 2008-04-17 |
| CA2664318A1 (en) | 2008-03-20 |
| JP2015013874A (ja) | 2015-01-22 |
| US20160051627A1 (en) | 2016-02-25 |
| US9155749B2 (en) | 2015-10-13 |
| CN101610793B (zh) | 2012-10-24 |
| KR20140029559A (ko) | 2014-03-10 |
| IL217840A (en) | 2013-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101470472B1 (ko) | 장기 지속형 약물 제형 | |
| KR101591887B1 (ko) | 장기 지속형 약물 제형 | |
| CN108753824B (zh) | 用于治疗视网膜营养不良的病毒载体 | |
| AU2024216517A1 (en) | Enhanced systems for cell-mediated oncolytic viral therapy | |
| KR20210149060A (ko) | Tn7-유사 트랜스포존을 사용한 rna-유도된 dna 통합 | |
| KR101982360B1 (ko) | 콤팩트 tale-뉴클레아제의 발생 방법 및 이의 용도 | |
| AU2025200704A1 (en) | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment | |
| KR102912481B1 (ko) | 유전자 편집된 t 세포에서의 인간 foxp3의 발현 | |
| KR20210151916A (ko) | 뒤시엔느 근육 이영양증의 치료를 위한 aav 벡터-매개된 큰 돌연변이 핫스팟의 결실 | |
| KR101471445B1 (ko) | 조류에서 이식유전자 발현 | |
| CA3041673A1 (en) | Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion | |
| CN111733174B (zh) | 一种分离的核酸分子及其用途 | |
| KR20180088484A (ko) | 프롤린 및 알라닌 잔기가 풍부한 반복적인 아미노산 서열을 암호화하고 낮은 반복적인 뉴클레오티드 서열을 갖는 핵산 | |
| CN113260704B (zh) | CYP4V2和RdCVF在制备药物中的用途 | |
| KR20180099719A (ko) | 눈 장애에 대한 유전자 요법 | |
| CN112203697A (zh) | 编码氨基己糖苷酶alpha和beta亚基的双顺反子AAV载体及其用途 | |
| CN112088015A (zh) | 人乳头瘤病毒疫苗及其用途 | |
| CN113372440A (zh) | 一种识别EB病毒gH糖蛋白的单克隆抗体及其应用 | |
| CN116323942A (zh) | 用于基因组编辑的组合物及其使用方法 | |
| KR20140116093A (ko) | 유방암을 치료하기 위한 방법 | |
| KR101970428B1 (ko) | 재조합 볼거리 바이러스 제릴린2계 백신 | |
| CN114250227B (zh) | 用于高水平表达外源基因的表达载体 | |
| CN114958762B (zh) | 一种构建神经组织特异过表达人源snca的帕金森病模型猪的方法及应用 | |
| AU2019231652B2 (en) | Hepatitis B vaccines and uses of the same | |
| CN101652475A (zh) | 在禽类中进行转基因表达 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| A201 | Request for examination | ||
| PA0104 | Divisional application for international application |
St.27 status event code: A-0-1-A10-A16-div-PA0104 St.27 status event code: A-0-1-A10-A18-div-PA0104 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
Fee payment year number: 1 St.27 status event code: A-2-2-U10-U12-oth-PR1002 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
Not in force date: 20171003 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE St.27 status event code: A-4-4-U10-U13-oth-PC1903 |
|
| PC1903 | Unpaid annual fee |
Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20171003 St.27 status event code: N-4-6-H10-H13-oth-PC1903 |